Analysen von Emmanuel Papadakis
| 23.07.20 | Roche overweight | Barclays Capital | |
| 15.07.20 | Bayer overweight | Barclays Capital | |
| 20.05.20 | AstraZeneca overweight | Barclays Capital | |
| 15.05.20 | Roche kaufen | Barclays Capital | |
| 13.05.20 | MorphoSys Equal weight | Barclays Capital | |
| 07.05.20 | Novo Nordisk overweight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 30.04.20 | GSK Underweight | Barclays Capital | |
|
Werbung
|
|||
| 09.04.20 | Bayer overweight | Barclays Capital | |
| 09.04.20 | AstraZeneca overweight | Barclays Capital | |
| 09.04.20 | GSK Underweight | Barclays Capital | |
| 09.04.20 | Novo Nordisk overweight | Barclays Capital | |
| 09.04.20 | Roche overweight | Barclays Capital | |
| 03.04.20 | Roche overweight | Barclays Capital | |
| 25.03.20 | MorphoSys Equal weight | Barclays Capital | |
| 24.03.20 | Bayer overweight | Barclays Capital | |
| 24.03.20 | MorphoSys Equal weight | Barclays Capital | |
| 17.03.20 | Roche overweight | Barclays Capital | |
| 17.03.20 | Novartis Underweight | Barclays Capital | |
| 17.03.20 | Novo Nordisk overweight | Barclays Capital | |
| 17.03.20 | GSK Underweight | Barclays Capital | |
| 17.03.20 | AstraZeneca overweight | Barclays Capital | |
| 17.03.20 | Bayer overweight | Barclays Capital | |
| 17.03.20 | Sanofi Equal weight | Barclays Capital | |
| 02.03.20 | Novo Nordisk overweight | Barclays Capital | |
| 27.02.20 | Bayer overweight | Barclays Capital | |
| 25.02.20 | Novartis Underweight | Barclays Capital | |
| 20.02.20 | Roche overweight | Barclays Capital | |
| 19.02.20 | Bayer overweight | Barclays Capital | |
| 18.02.20 | AstraZeneca overweight | Barclays Capital | |
| 10.02.20 | Sanofi Underweight | Barclays Capital | |
| 07.02.20 | GSK Underweight | Barclays Capital | |
| 06.02.20 | Novo Nordisk overweight | Barclays Capital | |
| 06.02.20 | Sanofi Underweight | Barclays Capital | |
| 05.02.20 | Novo Nordisk overweight | Barclays Capital | |
| 03.02.20 | MorphoSys Equal weight | Barclays Capital | |
| 31.01.20 | Novo Nordisk overweight | Barclays Capital | |
| 30.01.20 | Roche overweight | Barclays Capital | |
| 20.01.20 | Bayer overweight | Barclays Capital | |
| 17.01.20 | Novo Nordisk overweight | Barclays Capital | |
| 16.01.20 | Sanofi Underweight | Barclays Capital | |
| 16.01.20 | Novartis Underweight | Barclays Capital | |
| 16.01.20 | Novo Nordisk overweight | Barclays Capital | |
| 16.01.20 | Roche overweight | Barclays Capital | |
| 16.01.20 | AstraZeneca overweight | Barclays Capital | |
| 16.01.20 | GSK Underweight | Barclays Capital | |
| 16.01.20 | Bayer overweight | Barclays Capital | |
| 20.12.19 | Sanofi Underweight | Barclays Capital | |
| 06.12.19 | Sanofi Underweight | Barclays Capital | |
| 02.12.19 | Roche overweight | Barclays Capital | |